Human milk oligosaccharides protect against enteropathogenic escherichia coli attachment in vitro and EPEC colonization in suckling mice

Journal of Pediatric Gastroenterology and Nutrition

Volumn 58, Issue 2, 2014, Pages 165-168

  Manthey, Carolin F ^a   Autran, Chloe A ^b   Eckmann, Lars ^a   Bode, Lars ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

bacterial attachment; breast feeding; enteropathogenic Escherichia coli; human milk oligosaccharides

Indexed keywords

ANTIINFECTIVE AGENT; OLIGOSACCHARIDE;

ANIMAL; BACTERIUM ADHERENCE; BREAST FEEDING; BREAST MILK; C57BL MOUSE; CHEMISTRY; DIARRHEA; DRUG EFFECTS; ENTEROPATHOGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY;

ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIAL ADHESION; BREAST FEEDING; DIARRHEA; ENTEROPATHOGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; MICE, INBRED C57BL; MILK, HUMAN; OLIGOSACCHARIDES;

EID: 84894050994     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000000172     Document Type: Article

References (13)

1. Bode L. Human milk oligosaccharides: every baby needs a sugar mama. Glycobiology 2012;22:1147-62.
2. Bryce J, Boschi-Pinto C, Shibuya K, et al. WHO estimates of the causes of death in children. Lancet 2005;365:1147-52.
3. Frankel G, Phillips AD, Rosenshine I, et al. Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements. Mol Microbiol 1998;30:911-21.
4. Donnenberg MS, Kaper JB. Enteropathogenic Escherichia coli. Infect Immun 1992;60:3953-61.
5. Bardiau M, Szalo M, Mainil JG. Initial adherence of EPEC, EHEC and VTEC to host cells. Vet Res 2010;41:57.
6. Ruiz-Palacios GM, Cervantes LE, Ramos P, et al. Campylobacter jejuni binds intestinal H(O) antigen (Fuc alpha 1, 2Gal beta 1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection. J Biol Chem 2003;278:14112-20.
7. Savkovic SD, Villanueva J, Turner JR, et al. Mouse model of enter-opathogenic Escherichia coli infection. Infect Immun 2005;73:1161-70.
8. Jantscher-Krenn E, Zherebtsov M, Nissan C, et al. The human milk oligosaccharide disialyllacto-N-tetraose prevents necrotising enteroco-litis in neonatal rats. Gut 2012;61:1417-25.
9. Mundy R, Girard F, FitzGerald AJ, et al. Comparison of colonization dynamics and pathology of mice infected with enteropathogenic Escherichia coli, enterohaemorrhagic E. coli and Citrobacter rodentium. FEMS Microbiol Lett 2006;265:126-32.
10. Wong AR, Pearson JS, Bright MD, et al. Enteropathogenic and enter-ohaemorrhagic Escherichia coli: even more subversive elements. Mol Microbiol 2011;80:1420-38.
11. Hyland RM, Sun J, Griener TP, et al. The bundlin pilin protein of enteropathogenic Escherichia coli is an N-acetyllactosamine-specific lectin. Cell Microbiol 2008;10:177-87.
12. Frankel G, Phillips AD, Novakova M, et al. Intimin from enteropatho-genic Escherichia coli restores murine virulence to a Citrobacter rodentium eaeA mutant: induction of an immunoglobulin A response to intimin and EspB. Infect Immun 1996;64:5315-25.
13. Creek TL, Kim A, Lu L, et al. Hospitalization and mortality among primarily nonbreastfed children during a large outbreak of diarrhea and malnutrition in Botswana, 2006. J Acquir Immune Defic Syndr 2010; 53:14-9.